Katsuo Usuda, MD, PhD, from Kanazawa Medical University, Ishikawa, Japan argues that diffusion-weighted magnetic resonance imaging (DWI, MRI) will soon replace PET-CT for lung cancer diagnosis at the European Cancer Congress of the European Cancer Organisation (ECCO) 2017 in Amsterdam, Netherlands. He discusses the benefits of diffusion-weighted MRI, which is not only cheaper than PET-CT, but also does not expose the patient to radiation.
Will diffusion-weighted MRI replace PET-CT in lung cancer?
